P Visca Selected Research

P Visca Research Topics

Disease

7	Neoplasms (Cancer) 12/2020 - 11/2000
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 05/2008
2	Breast Neoplasms (Breast Cancer) 11/2008 - 07/2001
1	Adenocarcinoma of Lung 12/2020
1	Infections 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Mycoses (Diseases, Fungus) 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2015
1	Lung Neoplasms (Lung Cancer) 08/2015
1	Adenocarcinoma 08/2015
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 12/2010
1	Sarcoidosis (Schaumann Disease) 05/2010
1	Psoriatic Arthritis 05/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2010
1	Pulmonary Sarcoidosis 05/2010
1	Cardiotoxicity 11/2008
1	Margins of Excision 09/2008
1	Genetic Translocation (Chromosomal Translocation) 09/2008
1	Lymphadenitis (Adenitis) 07/2008
1	AIDS-Related Opportunistic Infections 07/2008
1	Cryptococcosis 07/2008
1	Latent Infection 07/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2008
1	Immune Reconstitution Inflammatory Syndrome 07/2008
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2006
1	Choroid Plexus Carcinoma 09/2005
1	Sarcoma (Soft Tissue Sarcoma) 11/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2001
1	Fibrosis (Cirrhosis) 08/2001
1	Hypoxia (Hypoxemia) 08/2001
1	Atherosclerosis 08/2001
1	Primary Myelofibrosis (Myelosclerosis) 08/2001
1	Aneuploidy (Aneuploid) 05/2001
1	Polyploidy 05/2001
1	Squamous Intraepithelial Lesions 05/2001
1	Papillomavirus Infections 05/2001
1	Melioidosis 01/2001
1	Bacterial Pneumonia 01/2001
1	Ovarian Neoplasms (Ovarian Cancer) 11/2000
1	Starvation 03/2000

Drug/Important Bio-Agent (IBA)

2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2008 - 08/2001
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 07/2001 - 11/2000
1	B7-H1 AntigenIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 12/2020
1	CytosineIBA 01/2016
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2016
1	Flucytosine (Ancobon)FDA Link 01/2016
1	Hyaluronic Acid (Hyaluronan)IBA 01/2016
1	SuspensionsIBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Tyrosine Kinase InhibitorsIBA 08/2015
1	ErbB Receptors (EGF Receptor)IBA 08/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2015
1	AntibodiesIBA 12/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010
1	Infliximab (Remicade)FDA Link 05/2010
1	AnthracyclinesIBA 11/2008
1	Docetaxel (Taxotere)FDA Link 11/2008
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 09/2008
1	AntigensIBA 07/2008
1	Tumor Biomarkers (Tumor Markers)IBA 05/2008
1	SurvivinIBA 05/2008
1	Viral DNAIBA 03/2005
1	Liposomes (Liposome)IBA 11/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2004
1	liposomal doxorubicin (Doxil)FDA Link 11/2004
1	LigandsIBA 08/2001
1	Oxygen (Dioxygen)IBA 08/2001
1	Platelet-Derived Growth FactorIBA 08/2001
1	platelet-derived growth factor AIBA 08/2001
1	Glucose Transporter Type 1IBA 07/2001
1	DNA (Deoxyribonucleic Acid)IBA 05/2001
1	fragile histidine triad proteinIBA 05/2001
1	Chloramphenicol (Chloromycetin)FDA Link 01/2001
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2001
1	Doxycycline (Periostat)FDA LinkGeneric 01/2001
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2000
1	EnzymesIBA 11/2000
1	IronIBA 03/2000
1	Sigma FactorIBA 03/2000

Therapy/Procedure

4	Therapeutics 01/2016 - 01/2001
3	Drug Therapy (Chemotherapy) 08/2015 - 09/2005
2	Aftercare (After-Treatment) 08/2015 - 11/2008
2	Highly Active Antiretroviral Therapy (HAART) 07/2008 - 01/2001
1	Immunotherapy 12/2020
1	Adjuvant Chemotherapy 11/2008
1	Radiotherapy 09/2008
1	Hysterectomy 09/2007